Just to add to this, I think ENOX2 is tumour-specific, so even if idronoxil has off-target effects these effects will most likely be confined to tumour tissues and not healthy tissues, making it ideal for treating cancer.
- Forums
- ASX - By Stock
- NOX
- BMS woes continue
BMS woes continue, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
11.8¢ |
Change
0.003(2.17%) |
Mkt cap ! $33.60M |
Open | High | Low | Value | Volume |
11.5¢ | 12.0¢ | 11.0¢ | $19.53K | 169.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 185174 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 149619 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 185188 | 0.115 |
8 | 658312 | 0.110 |
4 | 82523 | 0.105 |
6 | 130000 | 0.100 |
1 | 40000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 149619 | 2 |
0.125 | 207492 | 3 |
0.130 | 255577 | 3 |
0.135 | 81304 | 3 |
0.140 | 171838 | 7 |
Last trade - 15.38pm 04/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |